7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan (Q36129001)

12 August 2017

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan (English)

1 reference

12 August 2017

1 reference

Sung-Shuo Kao

1

1 reference

12 August 2017

Wen-Chi Chen

2

1 reference

12 August 2017

Ping-I Hsu

3

1 reference

12 August 2017

Kwok-Hung Lai

4

1 reference

12 August 2017

Hsien-Chung Yu

5

1 reference

12 August 2017

Hui-Hwa Cheng

6

1 reference

12 August 2017

Nan-Jing Peng

7

1 reference

12 August 2017

Chiun-Ku Lin

8

1 reference

12 August 2017

Hoi-Hung Chan

9

1 reference

12 August 2017

Wei-Lun Tsai

10

1 reference

12 August 2017

Huay-Min Wang

11

1 reference

12 August 2017

Tzung-Jiun Tsai

12

1 reference

12 August 2017

Kung-Hung Lin

13

1 reference

12 August 2017

Feng-Woei Tsay

14

1 reference

12 August 2017

22 July 2012

1 reference

Gastroenterology research and practice

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

463985

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Optimal therapy for Helicobacter pylori infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Helicobacter pylori treatment in the era of increasing antibiotic resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Sequential therapy for Helicobacter pylori eradication: a critical review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Smoking increases the treatment failure for Helicobacter pylori eradication

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Accurate diagnosis of Helicobacter pylori. Urease tests

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Understanding and appreciating sequential therapy for Helicobacter pylori eradication

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408719

Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F463985

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F463985

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

21 January 2018

1 reference

12 December 2020

Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece

1 reference

12 December 2020

Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis

1 reference

12 December 2020

One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

1 reference

12 December 2020

Infection with Helicobacter pylori

1 reference

12 December 2020

Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia

1 reference

12 December 2020

A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate

1 reference

12 December 2020

Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/463985

1 reference

12 August 2017

1 reference

12 August 2017

1 reference